Company intelligence / Profile preview

Lifesum

Ownership: Private
Development stage: Commercial

Overview

Lifesum offers a widely used digital health app for personalized nutrition tracking and meal planning. It provides features such as barcode scanning for food items, integration with wearables and fitness trackers, personalized meal plans including fasting programs and hormonal health plans. The company reports over 60 million users globally but does not conduct clinical trials or have drug/biologic products in development.

Therapeutic areas: Metabolic DisordersEndocrinologyNeurologyOther
Modalities: Non-pharmacological therapyDevice (mobile app/software platform)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Amazon HaloŌURA Ringintegrations with Apple HealthGoogle FitSamsung HealthAmazon (corporate client)General Electric (corporate client)PayPal (corporate client)

Beyond the preview

Go deeper on Lifesum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lifesum.

Explore the full profile